Ozempic vs Wegovy vs Mounjaro vs Zepbound: What's the Difference?
Educational information only. This article does not diagnose, treat, cure or prevent any condition and is not medical advice. All decisions about which medication — if any — is appropriate for you are a matter for you and your qualified healthcare professional.
There are really only two molecules here. Ozempic and Wegovy are both semaglutide — the same active ingredient, made by the same company, approved for different conditions. Mounjaro and Zepbound are both tirzepatide — again the same molecule, different brand name, different approved use. Understanding which is which makes the whole landscape much simpler to navigate.
The four brands at a glance
| Brand | Active molecule | Approved use | How it's taken |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes management | Weekly subcutaneous injection |
| Wegovy | Semaglutide | Chronic weight management | Weekly subcutaneous injection |
| Mounjaro | Tirzepatide | Type 2 diabetes management | Weekly subcutaneous injection |
| Zepbound | Tirzepatide | Chronic weight management | Weekly subcutaneous injection |
Why does the same molecule have two brand names?
Drug manufacturers often seek approval for the same active compound under different brand names for different clinical indications. This is partly a regulatory and commercial process: the approved doses, labelling, and clinical data package submitted to regulators differ between the diabetes and weight-loss indications, even though the molecule itself is the same.
In practice, this means Ozempic and Wegovy are both semaglutide — but the approved maximum doses and titration schedules for Wegovy (the weight-loss version) are higher than those for Ozempic (the diabetes version). Similarly, Zepbound's weight-loss dosing reflects its own approved schedule.
What's the difference between semaglutide and tirzepatide?
Semaglutide (Ozempic / Wegovy) is a GLP-1 receptor agonist — it mimics one gut hormone that signals fullness and slows gastric emptying. Tirzepatide (Mounjaro / Zepbound) is a dual GIP/GLP-1 agonist — it targets two receptors. In head-to-head clinical trial data (the SURMOUNT-5 trial), tirzepatide produced greater average weight loss than semaglutide, though individual responses vary considerably.
Which one is right for me?
That is a decision to make with your prescribing clinician. The right medication depends on your medical history, any existing conditions, insurance or cost considerations, and your prescriber's clinical judgement. No article can make that call for you — but going in knowing the landscape helps you ask better questions at your appointment.
Frequently asked
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, the same active molecule. Ozempic is approved for type 2 diabetes management; Wegovy is approved for weight loss (chronic weight management). The approved doses and titration schedules differ.
What is the difference between Mounjaro and Zepbound?
Both contain tirzepatide, the same active molecule. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight loss. Same molecule, different brand name and approved indication.
Is tirzepatide or semaglutide better for weight loss?
Head-to-head trial data (SURMOUNT-5) found tirzepatide produced greater average weight loss than semaglutide. The right choice depends on your individual situation — talk to your clinician about what fits your history and goals.
Can I get Wegovy or Zepbound if I have diabetes?
Approved indications are set by regulators, and prescribing decisions are made by your clinician based on your full medical picture. Talk to your doctor about which medication — and which brand — is appropriate for you.
Educational information only. This article does not diagnose, treat, cure or prevent any condition and is not medical advice. Decisions about which weight-loss or diabetes medication is right for you are a matter for you and your qualified healthcare professional.